Oncimmune Holdings (GB:ONC) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Oncimmune Holdings, a leader in autoantibody profiling for precision medicine, has distributed a Circular to its shareholders outlining details of its upcoming General Meeting. This meeting, scheduled for November 8, 2024, is set to address resolutions for Fundraising and Debt Restructuring. The company’s initiative aims to bolster its financial health and enhance its collaborations in the pharmaceutical and biotech sectors.
For further insights into GB:ONC stock, check out TipRanks’ Stock Analysis page.
